Form 8-K - Current report:
SEC Accession No. 0001104659-25-124293
Filing Date
2025-12-23
Accepted
2025-12-23 17:16:00
Documents
12
Period of Report
2025-12-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2534154d1_8k.htm   iXBRL 8-K 35752
  Complete submission text file 0001104659-25-124293.txt   203833

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxs-20251217.xsd EX-101.SCH 3017
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20251217_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20251217_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2534154d1_8k_htm.xml XML 3218
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 251601714
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)